11 Results for "

antiglioma

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "antiglioma" in MCE Product Catalog:

7
7 Publications Verification
Cat. No.: HY-144828
CAS No.: 2682850-41-3
Purity:  ≥97.0%
Research Areas:  

Cancer

RIP1/RIP3/MLKL activator 1 (Compound 6i) is a potent anti-glioma agent. RIP1/RIP3/MLKL activator 1 induces necroptosis through RIP1/RIP3/MLKL pathway. RIP1/RIP3/MLKL activator 1 exerts acceptable BBB permeability .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-N1438
CAS No.: 20243-59-8
Synonyms: 7-O-Methylluteolin
Hydroxygenkwanin (7-O-Methylluteolin), a natural flavonoid compound, is one of the main components of Lilac Daphne. Hydroxygenkwanin has anti-oxidant ability, anti-glioma ability and anticancer effect .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-113974
CAS No.: 885012-33-9
Purity:  98.16%
Synonyms: t-AUCB
Target:  

Epoxide Hydrolase

Research Areas:  

Cancer

trans-AUCB (t-AUCB) is a potent, orally active and selective soluble epoxide hydrolase (sEH) inhibitor with IC50s of 1.3 nM, 8 nM, 8 nM for hsEH, mouse sEH and rat sEH, respectively. trans-AUCB has anti-glioma activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0459
CAS No.: 498-45-3
Synonyms: 6,7-Epoxytropine
Scopine is a metabolite of Scopolamine (HY-N0296) and brain-targeting compound. Scopine significantly increases the brain exposure of Chlorambucil (HY-13593) and enhances its anti-glioma activity. Scopine can be used in targeted therapy research for brain gliomas .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0459A
CAS No.: 85700-55-6
Synonyms: 6,7-Epoxytropine hydrochloride
Target:  

Drug Metabolite

Research Areas:  

Neurological Disease Cancer

Scopine hydrochloride is a metabolite of Scopolamine (HY-N0296) and brain-targeting compound. Scopine hydrochloride significantly increases the brain exposure of Chlorambucil (HY-13593) and enhances its anti-glioma activity. Scopine hydrochloride can be used in targeted therapy research for brain gliomas .
loading...
    loading...
Cat. No.: HY-117651
CAS No.: 16518-94-8
Purity:  ≥98.0%
Target:  

Acyltransferase

Research Areas:  

Cancer

2-Fluoropalmitic acid, an acyl-CoA synthetase inhibitor, acts as a candidate anti-glioma agent. 2-Fluoropalmitic acid suppresses the viability and stem-like phenotype of glioma stem cells (GSCs). 2-Fluoropalmitic acid also inhibits proliferation and invasion of glioma cell lines .
loading...
    loading...
Cat. No.: HY-N9341
CAS No.: 22172-15-2
Norswertianin, a xanthone compound, serves as a powerful anti-glioma compound. Norswertianin induces GBM cells differentiation through oxidative stress and Akt/mTOR dependent autophagy .
loading...
    loading...
Cat. No.: HY-N1438R
CAS No.: 20243-59-8
Synonyms: 7-O-Methylluteolin (Standard)
Hydroxygenkwanin (Standard) is the analytical standard of Hydroxygenkwanin. This product is intended for research and analytical applications. Hydroxygenkwanin (7-O-Methylluteolin), a natural flavonoid compound, is one of the main components of Lilac Daphne. Hydroxygenkwanin has anti-oxidant ability, anti-glioma ability and anticancer effect .
loading...
    loading...
Cat. No.: HY-144825
Research Areas:  

Cancer

Chol-CTPP is a ligand with dual targeting effect on blood-brain barrier (BBB) and glioma cells. Lip-CTPP can be gained by Chol-CTPP and another mitochondria targeting ligand (Chol-TPP). Lip-CTPP is a promising potential carrier to exert the anti-glioma effect of doxorubicin (DOX) and lonidamine (LND) collaboratively. Lip-CTPP elevates the inhibition rate of tumor cell proliferation, migration and invasion, promote apoptosis and necrosis, and interfere with mitochondrial function .
loading...
    loading...
Cat. No.: HY-155464
Target:  

VEGFR Aurora Kinase

Research Areas:  

Cancer

VEGFR-2/AURKA-IN-1 (compound 5e) is a thiazolidin-4-one derivative with antiglioma activity (IC50: 6.43 μM, LN229). VEGFR-2/AURKA-IN-1 has affinity for AURKA and VEGFR-2 and is a potential ligand. VEGFR-2/AURKA-IN-1 causes DNA strand breaks and exhibits cytotoxic and anticancer potential .
loading...
    loading...
Cat. No.: HY-187593
CAS No.: 1186496-84-3
Research Areas:  

Neurological Disease Cancer

PLHSpT is an inhibitor of the Polo-box domain (PBD) of Polo-like kinase 1 (Plk1), with an IC50 of 36 μM. It binds to the PB1-PB2 cleft of the Plk1 PBD to block its interaction with phosphoprotein substrates, thereby inducing mitotic arrest and apoptosis in tumor cells. PLHSpT exerts antiglioma effects when delivered via liposomes, and it is applicable to research on glioblastoma multiforme and other human cancers .
loading...
    loading...
  • 1